Ezetimibe plus fenofibrate: a new combination therapy for the management of mixed hyperlipidaemia?

about

Update on the clinical utility of fenofibrate in mixed dyslipidemias: mechanisms of action and rational prescribing.

P2860

Q37019924-7C4DBA57-C827-4C55-9DEA-301D9E24E031

P2860

Ezetimibe plus fenofibrate: a new combination therapy for the management of mixed hyperlipidaemia?

Item

http://www.wikidata.org/entity/Q36847314

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Ezetimibe plus fenofibrate: a ...... ment of mixed hyperlipidaemia?

@en

type

Item

label

Ezetimibe plus fenofibrate: a ...... ment of mixed hyperlipidaemia?

@en

prefLabel

Ezetimibe plus fenofibrate: a ...... ment of mixed hyperlipidaemia?

@en

P1476

Ezetimibe plus fenofibrate: a ...... ment of mixed hyperlipidaemia?

@en

P2093

Michel Farnier

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Pharmacology and therapeutics of ezetimibe (SCH 58235), a cholesterol-absorption inhibitor

Dyslipidaemia

Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia

Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome

The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)

Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

P304

1345-1352

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.8.9.1345

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17563268

http://www.w3.org/2001/XMLSchema#string

P921

hyperlipidemia

Ezetimibe plus fenofibrate: a new combination therapy for the management of mixed hyperlipidaemia?

about

P2860

P2860

Ezetimibe plus fenofibrate: a new combination therapy for the management of mixed hyperlipidaemia?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921